Clinical trial
Continuous Application of Lisuride in Parkinson's Disease by Subcutaneous…
NCT00408915 · Axxonis Pharma AG, Industry · Completed
Key facts
| NCT number | NCT00408915 |
|---|---|
| Title | Continuous Application of Lisuride in Parkinson's Disease by Subcutaneous Infusion |
| Official title | Double-blind, Placebo-controlled, Randomized, Multicentre Phase II/III Study to Evaluate the Efficacy and Safety of Lisuride, Applied Subcutaneously by Means of a Minipump in Patients With Advanced Parkinson's Disease Refractory to Conventional Oral Therapy |
| Lead sponsor | Axxonis Pharma AG, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug |
| Interventions | Continuous Subcutaneous Lisuride Infusion |
| Enrollment | 60 |
| Start date | Jul 1, 2006 |
| First posted | Dec 7, 2006 |
| Last update posted | Mar 7, 2012 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: